Kerafast Inc.

Doing business as Absolute Antibody Part of Lifespan Biosciences, Inc.

UEI
UPZ8NTQMGXB6
CAGE
7JS79
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
kerafast.com
Founded
2010
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Similar vendors

About the company

Kerafast, Inc., doing business as Absolute Antibody, is a corporate entity that provides research tools such as cell lines, antibodies, and other products to life science laboratories. According to its website, Kerafast operates an e-commerce portal to make unique laboratory-made research tools more accessible to the global scientific community.

Through prime federal contract awards, Kerafast has provided various antibodies and antibody production services to the National Institutes of Health. This includes anti-CD20 and anti-VSV-G antibodies provided to National Institute of Allergy and Infectious Diseases, another antibody reagent for the National Cancer Institute, and a silver-level antibody modification and production service for National Institute of Allergy and Infectious Diseases. Some awards were set aside for total small businesses. Kerafast also provided an anti-VSV-G antibody for National Institute of Allergy and Infectious Diseases related to the Coronavirus COVID-19 national interest action. In summary, Kerafast has specialized in supplying antibodies and related research tools to NIH institutes through federal contracts.

Quick answers

Is Kerafast Inc. registered in SAM.gov?

Kerafast Inc.'s SAM.gov registration expired on March 27, 2026.

What is Kerafast Inc.'s most recent federal award?

Kerafast Inc.'s most recent federal contract award is Anti-CD20 [18B12] (75N93021P00808), from National Institute of Allergy and Infectious Diseases (NIH), on June 11, 2021.

On GovTribe

See Kerafast Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors